SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001317757-08-000008
Filing Date
2008-12-22
Accepted
2008-12-22 17:14:18
Documents
1
Period of Report
2008-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4052
  Complete submission text file 0001317757-08-000008.txt   5994
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Issuer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address (617) 498-3300
Bonventre Joseph Vincent (Reporting) CIK: 0001428255 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14732 | Film No.: 081264593